Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Amyloidosis × pegfilgrastim × Clear all

Sponsor

Conditions

Breast Neoplasms 25 Lymphoma 15 Neutropenia 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Triple Negative Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Hodgkin Disease 4 Chemotherapy-induced Neutropenia 4 Urinary Bladder Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Colorectal Neoplasms 3 Burkitt Lymphoma 3 Breast Neoplasms, Male 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Adenocarcinoma of Lung 3 Waldenstrom Macroglobulinemia 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma 2

Interventions

Dexamethasone 9 Calcium Dobesilate 7 Bortezomib 5 Melphalan 4 Cyclophosphamide 3 ixazomib 2 Thalidomide 2 Doxycycline 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 birtamimab 1 auricularum 1 Tacrolimus 1 Lenalidomide 1 Etoposide 1 Doxorubicin 1 Cisplatin 1 Bendamustine Hydrochloride 1 Antilymphocyte Serum 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡